Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioTelemetry built one of the world’s largest remote cardiac monitoring networks and was a market leader in mobile cardiac outpatient telemetry (MCOT) and other ambulatory ECG solutions. The company also provided centralized core laboratory services for clinical trials and remote blood glucose monitoring. Its proprietary MCOT system offered continuous heartbeat-to-heartbeat ECG analysis with advanced algorithms for arrhythmia detection. At acquisition in 2021 by Philips, it served over one million patients per year with $450 million in annual sales[6][5][1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioTelemetry.